SCHEMBL24926464

SCHEMBL24926464

CCN(CS)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.55
KDM4E B2RXH2 1/20 0.55
TSHR P16473 3/20 0.53
MAPK1 P28482 1/20 0.53
HRH3 Q9Y5N1 1/20 0.50
BCHE P06276 1/20 0.49
CHRM2 P08172 1/20 0.48
HTR1A P08908 1/20 0.48
ADRA2A P08913 1/20 0.48
CHRM1 P11229 1/20 0.48
DRD1 P21728 1/20 0.48
SLC6A2 P23975 1/20 0.48
SLC6A4 P31645 1/20 0.48
ADRA1A P35348 1/20 0.48
OPRM1 P35372 1/20 0.48
DRD3 P35462 1/20 0.48
SLC6A3 Q01959 1/20 0.48
KCNH2 Q12809 1/20 0.48
ALDH1A1 P00352 2/20 0.48
MAOB P27338 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL81248 0.86 HRH3 (0.65) CNR2KDM4ETSHRMAPK1HRH3
SCHEMBL375111 0.86 KDM4E (0.68) CNR2KDM4ETSHRMAPK1HRH3
SCHEMBL1754765 0.86 TSHR (0.50) CNR2KDM4ETSHRMAPK1OPRM1
Fluoride SCHEMBL11307410 0.84 HRH3 (0.62) CNR2KDM4ETSHRMAPK1HRH3
Iodide SCHEMBL21693881 0.84 HRH3 (0.62) CNR2KDM4ETSHRMAPK1HRH3
Hydrochloric Acid SCHEMBL11608574 0.84 KDM4E (0.66) CNR2KDM4ETSHRMAPK1HRH3
Bromide SCHEMBL11663269 0.84 HRH3 (0.62) CNR2KDM4ETSHRMAPK1HRH3
Water SCHEMBL5507580 0.84 HRH3 (0.62) CNR2KDM4ETSHRMAPK1HRH3
Hydrochloric Acid SCHEMBL890978 0.84 HRH3 (0.62) CNR2KDM4ETSHRMAPK1HRH3
SCHEMBL12763727 0.84 CNR2 (0.67) CNR2KDM4ETSHRMAPK1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230031954-A1 TETRACYCLINE COMPOUNDS AND METHODS OF TREATMENT TETRAPHASE PHARMACEUTICALS, INC. 2023-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230031954-A1 TETRACYCLINE COMPOUNDS AND METHODS OF TREATMENT MCL1, ABL1, MALT1 CNR2 4800/4885KDM4E 378/4885TSHR 1458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.